We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+14.34%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$4.49B
AUM Growth
+$274M
Cap. Flow
-$202M
Cap. Flow %
-4.5%
Top 10 Hldgs %
17.39%
Holding
140
New
5
Increased
37
Reduced
95
Closed
3

Top Buys

Rank Stock Value
1
EHTH icon
eHealth
EHTH
+$21.7M
2
BOX icon
Box
BOX
+$18.8M
3
CHRS icon
Coherus Oncology
CHRS
+$5.41M
4
HQY icon
HealthEquity
HQY
+$4.81M
5
FANG icon
Diamondback Energy
FANG
+$4.62M

Sector Composition

Rank Sector Weight
1 Industrials 22.3%
2 Technology 17.03%
3 Healthcare 15.26%
4 Financials 14.45%
5 Consumer Discretionary 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRL icon
1
Charles River Laboratories
CRL
$11.3B
$94.4M 2.1%
325,682
-30,090
-8% -$8.36M
MMSI icon
2
Merit Medical Systems
MMSI
$4.82B
$83.4M 1.85%
1,392,251
-65,253
-4% -$3.74M
DY icon
3
Dycom Industries
DY
$11.2B
$83M 1.85%
894,138
-36,544
-4% -$3.17M
ITRI icon
4
Itron
ITRI
$4.48B
$78.5M 1.75%
885,514
-40,656
-4% -$4.02M
ACHC icon
5
Acadia Healthcare
ACHC
$2.55B
$78.3M 1.74%
1,369,893
-59,973
-4% -$3.25M
AEIS icon
6
Advanced Energy
AEIS
$10.1B
$76.9M 1.71%
704,074
-99,838
-12% -$10.8M
EFOR
7
Everforth Inc
EFOR
$960M
$76.7M 1.71%
803,331
-37,697
-4% -$3.48M
HMSY
8
DELISTED
HMS Holdings Corp.
HMSY
$74.5M 1.66%
2,015,847
-135,092
-6% -$4.96M
QTS
9
DELISTED
QTS REALTY TRUST, INC.
QTS
$68.7M 1.53%
1,107,659
-52,402
-5% -$3.27M
MTSI icon
10
MACOM Technology Solutions
MTSI
$17.4B
$67.1M 1.49%
1,157,078
-159,518
-12% -$9.89M
AER icon
11
AerCap
AER
$23.4B
$65.6M 1.46%
1,116,057
-54,567
-5% -$2.66M
PPBI
12
DELISTED
Pacific Premier Bancorp
PPBI
$65.5M 1.46%
1,506,753
-478,121
-24% -$18.6M
ROG icon
13
Rogers Corp
ROG
$2.09B
$64.9M 1.44%
344,895
-16,052
-4% -$2.87M
NBHC icon
14
National Bank Holdings
NBHC
$1.9B
$64.4M 1.43%
1,624,158
-74,014
-4% -$2.77M
ALE
15
DELISTED
Allete
ALE
$62.4M 1.39%
928,992
-29,435
-3% -$1.93M
ACIW icon
16
ACI Worldwide
ACIW
$6.12B
$61.3M 1.36%
1,611,648
-76,038
-5% -$3M
CRI icon
17
Carter's
CRI
$1.43B
$60.9M 1.35%
684,484
-31,456
-4% -$2.91M
EPAY
18
DELISTED
Bottomline Technologies Inc
EPAY
$60.3M 1.34%
1,331,577
-63,148
-5% -$3.04M
MNRO icon
19
Monro
MNRO
$415M
$57.8M 1.29%
878,147
-40,709
-4% -$2.55M
KN icon
20
Knowles
KN
$2.95B
$56.1M 1.25%
2,682,212
-112,555
-4% -$2.29M
CHE icon
21
Chemed
CHE
$7.16B
$56.1M 1.25%
121,997
-5,933
-5% -$2.91M
AIMC
22
DELISTED
Altra Industrial Motion Corp
AIMC
$54.7M 1.22%
988,588
-48,489
-5% -$2.82M
AZPN
23
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$54.1M 1.2%
374,903
-16,935
-4% -$2.44M
MODV
24
DELISTED
ModivCare
MODV
$54M 1.2%
364,622
-23,909
-6% -$3.71M
EEFT icon
25
Euronet Worldwide
EEFT
$3.19B
$53.4M 1.19%
385,929
-18,081
-4% -$2.61M

Similar funds

Aristotle Capital Boston's Q1 2021 Portfolio in Review

As of Q1 2021, Aristotle Capital Boston held 140 positions worth $4.49B, up 6.5% from $4.22B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Aristotle Capital Boston withdrew a net $202M in Q1 2021, closing 3 positions and reducing 95 holdings. Its most notable exit was QEP RESOURCES, INC., an estimated $3.66M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aristotle Capital Boston opened a new position in eHealth worth $24.6M.

  • Aristotle Capital Boston's largest Q1 2021 buy was eHealth: 338,806 shares worth $24.6M.
  • Aristotle Capital Boston added most to Coherus Oncology in Q1 2021, an estimated $5.41M increase.
  • Aristotle Capital Boston's biggest Q1 2021 reduction was Evercore, cutting an estimated $19.7M.
  • Aristotle Capital Boston fully exited QEP RESOURCES, INC. in Q1 2021, selling an estimated $3.66M.
  • Aristotle Capital Boston's ten largest holdings make up 17% of its $4.49B portfolio in Q1 2021.
  • Aristotle Capital Boston opened 5 new positions and closed 3 in Q1 2021.
  • Aristotle Capital Boston's portfolio value rose 6.5% quarter-over-quarter to $4.49B.

Based on Aristotle Capital Boston's 13F filing for Q1 2021, filed 17 May 2021.